Download PDF
Homeopathy 2024; 113(03): 186-189
DOI: 10.1055/s-0043-1775815
Clinical Case Report

Successful Treatment of a Fibromyalgia Patient Using a Homeopathic Preparation of Cannabis sativa

Jozélio Freire de Carvalho 
1   Institute for Health Sciences, Federal University of Bahia, Salvador, Bahia, Brazil
2   Núcleo de Pesquisa em Doenças Crônicas não Transmissíveis (NUPEN), School of Nutrition, Federal University of Bahia, Salvador, Bahia, Brazil
,
Maria Fernanda Leal dos Santos Ribeiro
3   UNEX University Center School of Medicine, Feira de Santana, Bahia, Brazil
› Author Affiliations Fundings None.
› Further Information
Also available at
    Permissions and Reprints

Abstract

Background Homeopathy has been used in observational and controlled studies to treat patients with fibromyalgia (FM), but none has previously used the remedy Cannabis sativa.

Case History A 51-year-old female patient presenting with diffuse pain and sleep disorder was diagnosed with FM using the relevant American College of Rheumatology criteria. She reported having 18 tender points, a pain score (visual analog scale, VAS) of 9.0, and a well-being VAS of 5.0. She was prescribed Cannabis sativa 6 cH, five drops sublingually thrice a day.

Results After 2 months, she returned asymptomatic, with 0 tender points, pain VAS of 0, and well-being VAS of 9.0. The Modified Naranjo Criteria for Homeopathy score was equal to +9, suggesting the clinical outcome was causally attributable to the medicine prescribed.

Conclusion This case study reveals the positive role of homeopathic treatment in FM. Studies using a randomized controlled design, including pragmatic trials to determine treatment effectiveness in real-world clinical practice, are indicated in this field.

Keywords

cannabis - fibromyalgia - chronic condition - homeopathy

Supplementary Material



Publication History

Received: 12 May 2023

Accepted: 13 July 2023

Article published online:
30 October 2023

© 2023. Faculty of Homeopathy. This article is published by Thieme.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Ruschak I, Montesó-Curto P, Rosselló L, Martín CA, Sánchez-Montesó L, Toussaint L. Fibromyalgia syndrome pain in men and women: a scoping review. Healthcare (Basel) 2023; 11: 223
    CrossrefPubMedSearch in Google Scholar
  • 2 Nishishinya B, Urrútia G, Walitt B. et al. Amitriptyline in the treatment of fibromyalgia: a systematic review of its efficacy. Rheumatology (Oxford) 2008; 47: 1741-1746
    CrossrefPubMedSearch in Google Scholar
  • 3 Crofford LJ, Appleton BE. Complementary and alternative therapies for fibromyalgia. Curr Rheumatol Rep 2001; 3: 147-156
    CrossrefPubMedSearch in Google Scholar
  • 4 Dimmock S, Troughton PR, Bird HA. Factors predisposing to the resort of complementary therapies in patients with fibromyalgia. Clin Rheumatol 1996; 15: 478-482
    CrossrefPubMedSearch in Google Scholar
  • 5 Thompson EA, Mathie RT, Baitson ES. et al. Towards standard setting for patient-reported outcomes in the NHS homeopathic hospitals. Homeopathy 2008; 97: 114-121
    Thieme ConnectPubMedSearch in Google Scholar
  • 6 Boehm K, Raak C, Cramer H, Lauche R, Ostermann T. Homeopathy in the treatment of fibromyalgia—a comprehensive literature review and meta-analysis. Complement Ther Med 2014; 22: 731-742
    CrossrefPubMedSearch in Google Scholar
  • 7 Khurshid H, Qureshi IA, Jahan N. et al. A systematic review of fibromyalgia and recent advancements in treatment: is medicinal cannabis a new hope?. Cureus 2021; 13: e17332
    PubMedSearch in Google Scholar
  • 8 van Haselen RA. Homeopathic clinical case reports: development of a supplement (HOM-CASE) to the CARE clinical case reporting guideline. Complement Ther Med 2016; 25: 78-85
    CrossrefPubMedSearch in Google Scholar
  • 9 Wolfe F, Clauw DJ, Fitzcharles MA. et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken) 2010; 62: 600-610
    CrossrefPubMedSearch in Google Scholar
  • 10 Lamba CD, Gupta VK, van Haselen R. et al. Evaluation of the Modified Naranjo Criteria for assessing causal attribution of clinical outcome to homeopathic intervention as presented in case reports. Homeopathy 2020; 109: 191-197
    Thieme ConnectPubMedSearch in Google Scholar
  • 11 Katz-Talmor D, Katz I, Porat-Katz BS, Shoenfeld Y. Cannabinoids for the treatment of rheumatic diseases—where do we stand?. Nat Rev Rheumatol 2018; 14: 488-498
    CrossrefPubMedSearch in Google Scholar
  • 12 Sukul NC, Bala SK, Bhattacharyya B. Prolonged cataleptogenic effects of potentized homoeopathic drugs. Psychopharmacology (Berl) 1986; 89: 338-339
    CrossrefPubMedSearch in Google Scholar
  • 13 Naudé DF, Couchman IMS, Maharaj A. Chronic primary insomnia: efficacy of homeopathic simillimum. Homeopathy 2010; 99: 63-68
    Thieme ConnectPubMedSearch in Google Scholar
  • 14 Homeopathy Pharmacopoeia of India. Combined Volume I to V (revised and augmented). New Delhi: Govt. of India, Ministry of Health and Family Welfare; 2016. : 151 & 40
    Search in Google Scholar
  • 15 Boericke W. Pocket Manual of Homoeopathic Materia Medica. Indian ed. Calcutta: Sett Dey; 1976: 160
    Search in Google Scholar